{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:04:51Z","timestamp":1788825891546,"version":"build-2803163510"},"reference-count":82,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Russian Science Foundation","award":["23-15-00069"],"award-info":[{"award-number":["23-15-00069"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Uterine leiomyomas are the most common benign tumors in women of childbearing age. They may lead to problems of conception or complications during the gestational period. The methods of treatment include surgical (myomectomy and hysterectomy, embolization of arteries) and therapeutic treatment (ulipristal acetate, leuprolide acetate, cetrorelix, goserelin, mifepristone). Both approaches are efficient but incompatible with pregnancy planning. Therefore, there is a call for medical practice to develop therapeutical means of preventing leiomyoma onset in patients planning on becoming pregnant. Based on the analysis of GWAS data on the search for mononucleotide polymorphisms associated with the risk of leiomyoma, in meta-transcriptomic and meta-methylomic studies, target proteins have been proposed. Prospective therapeutic treatments of leiomyoma may be based on chemical compounds, humanized recombinant antibodies, vaccines based on markers of the uterine leiomyoma cells that are absent in the adult organism, or DNA and RNA preparations. Three different nosological forms of the disease associated with driver mutations in the MED12, HMGA2, and FH genes should be considered when developing or prescribing drugs. For example, synthetic inhibitors and vaccines based on matrix metalloproteinases MMP11 and MMP16 are expected to be effective only for the prevention of the occurrence of MED12-dependent nodules.<\/jats:p>","DOI":"10.3390\/diseases11040156","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T02:05:07Z","timestamp":1698890707000},"page":"156","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Novel Approaches to Possible Targeted Therapies and Prophylaxis of Uterine Fibroids"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3790-0427","authenticated-orcid":false,"given":"Maria V.","family":"Kuznetsova","sequence":"first","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narine M.","family":"Tonoyan","sequence":"additional","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena V.","family":"Trubnikova","sequence":"additional","affiliation":[{"name":"Genetics Research Laboratory, Kursk State University, 305000 Kursk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry V.","family":"Zelensky","sequence":"additional","affiliation":[{"name":"Valuiky Central District Hospital, 309996 Valuiky, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ksenia A.","family":"Svirepova","sequence":"additional","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila V.","family":"Adamyan","sequence":"additional","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry Y.","family":"Trofimov","sequence":"additional","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennady T.","family":"Sukhikh","sequence":"additional","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,1]]},"reference":[{"key":"ref_1","first-page":"16","article-title":"Uterine fibrosis in young patients: Clinical and pathogenetic","volume":"4","author":"Sidorova","year":"2010","journal-title":"Obstet. Gynecol. Reprod."},{"key":"ref_2","unstructured":"Krasnopolsky, I.V. (2010). Operative Gynecology, Medpress-Inform."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.26442\/2075-1753_2018.6.26-30","article-title":"Ethnogeography of uterine fibroids: Epidemiology, age and race differences, types of surgery","volume":"20","author":"Arutyunova","year":"2018","journal-title":"Cons. Medicum"},{"key":"ref_4","unstructured":"Krasnopol\u2019skii, V.I., Logutova, L.S., and Buianova, S.N. (2008). Reproduktivnye Problem Operirovannoi Matki, Miklosh."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bpobgyn.2008.01.008","article-title":"Clinical presentation of fibroids","volume":"22","author":"Gupta","year":"2008","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_6","unstructured":"Vikhlyaeva, E.M., Zheleznov, B.I., and Zaporozhan, V.N. (1997). Rukovodstvo po Endokrinnoi Ginekologii, Meditsinskoe Informatsionnoe Agenstvo."},{"key":"ref_7","first-page":"3","article-title":"Epidemiology and risk factors for uterine fibroids, the best prakt","volume":"46","author":"Pavone","year":"2018","journal-title":"Res. Wedge. Obstetrics. Gynecol."},{"key":"ref_8","first-page":"85","article-title":"Benign metastatic uterine leiomyoma with lung damage: Problems of diagnosis and treatment and treatment","volume":"9","author":"Pechetov","year":"2020","journal-title":"Surgery"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00404-017-4494-6","article-title":"Pathobiology of uterine myomatosis: Basic knowledge necessary to support our clinical practice","volume":"296","author":"Becker","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0889-8545(16)30047-X","article-title":"Hysterectomy and alternative options","volume":"43","author":"Occhino","year":"2016","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"ref_11","first-page":"1091","article-title":"The frequency of hysterectomies in the United States","volume":"110","author":"Wu","year":"2007","journal-title":"Obstetrician-gynecologist"},{"key":"ref_12","first-page":"231","article-title":"Modern and emerging methods of treatment of uterine fibroids","volume":"3","author":"Dukhan","year":"2011","journal-title":"Int. J. Womens Health"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ajog.2011.12.002","article-title":"Estimated annual cost of uterine leiomyoma treatment in the United States","volume":"206","author":"Cardozo","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3389\/fgene.2019.00511","article-title":"A Trans-Ethnic Genome-Wide Association Study of Uterine Fibroids","volume":"10","author":"Edwards","year":"2019","journal-title":"Font. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejogrb.2020.06.039","article-title":"Prolapse of cervical fibroids during pregnancy","volume":"252","year":"2020","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: A systematic review","volume":"124","author":"Stewart","year":"2017","journal-title":"BJOG"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/jog.13519","article-title":"Recurrence of uterine myoma after myomectomy: Open myomectomy versus laparoscopic myomectomy","volume":"44","author":"Kotani","year":"2018","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3109\/00016348909006147","article-title":"Estrogen and progesterone receptors in uterine leiomyomas","volume":"68","author":"Marugo","year":"1989","journal-title":"Acta Obs. Gynecol. Scand."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000132682","article-title":"Karyotypic rearrangements in 20 uterine leiomyomas","volume":"49","author":"Nilbert","year":"1988","journal-title":"Cytogenet Cell Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000294895","article-title":"Independent origin of uterin leiomyomas with karyotypically identica alteratios","volume":"33","author":"Nilbert","year":"1992","journal-title":"Gynecol. Obstet. Investig."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0165-4608(90)90067-K","article-title":"Trisomy 12 in uterine leiomyomas. A new cytogenetic subgroup","volume":"45","author":"Nilbert","year":"1990","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0165-4608(96)00283-X","article-title":"HMGIC expressed in a uterine leiomyoma with a deletion of the long arm of chromosome 7 along with a 12q14-15 rearrangement but not in tumors showing del(7) as the sole cytogenetic abnormality","volume":"96","author":"Hennig","year":"1997","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0002-9440(10)65469-7","article-title":"Misexpression of wild-type and truncated isoforms of the high-mobility group I proteins HMGI-C and HMGI(Y) in uterine leiomyomas","volume":"155","author":"Wasserfall","year":"1999","journal-title":"Am. J. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/gcc.20627","article-title":"Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease","volume":"48","author":"Klemke","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cancergencyto.2009.09.021","article-title":"Loss of let-7 binding sites resulting from truncations of the 3\u2032 untranslated region of HMGA2 mRNA in uterine leiomyomas","volume":"196","author":"Klemke","year":"2010","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/gcc.20777","article-title":"HMGA2 and the p19Arf-TP53-CDKN1A axis: A delicate balance in the growth of uterine leiomyomas","volume":"49","author":"Markowski","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/gcc.22001","article-title":"Identification of CUX1 as the recurrent chromosomal band 7q22 target gene in human uterine leiomyoma","volume":"52","author":"Schoenmakers","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13039-014-0088-1","article-title":"Cytogenetically normal uterine leiomyomas without MED12-mutations\u2014A source to identify unknown mechanisms of the development of uterine smooth muscle tumors","volume":"7","author":"Holzmann","year":"2014","journal-title":"Mol. Cytogenet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/gcc.22317","article-title":"Detection and screening of chromosomal rearrangements in uterine leiomyomas by long-distance inverse PCR","volume":"55","author":"Pradhan","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12943-017-0672-1","article-title":"Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors","volume":"16","author":"Frizzell","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.1158\/0008-5472.CAN-17-1744","article-title":"Subtype-Specific Tumor-Associated Fibroblasts Contribute to the Pathogenesis of Uterine Leiomyoma","volume":"77","author":"Wu","year":"2017","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.fertnstert.2015.04.021","article-title":"Stro-1\/CD44 as putative human myometrial and fibroid stem cell markers","volume":"104","author":"Mas","year":"2015","journal-title":"Fertil. Steril."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3892\/etm.2015.2924","article-title":"IGF-1 and VEGF can be used as prognostic indicators for patients with uterine fibroids treated with uterine artery embolization","volume":"11","author":"Mu","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_34","first-page":"hoy020","article-title":"MED12 mutations and fumarate hydratase inactivation in uterine adenomyomas","volume":"4","author":"Heikkinen","year":"2018","journal-title":"Hum. Reprod. Open"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bpobgyn.2015.11.015","article-title":"Hormones and pathogenesis of uterine fibroids","volume":"34","author":"Reis","year":"2016","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s41588-018-0170-4","article-title":"Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair","volume":"50","author":"Sulkowski","year":"2018","journal-title":"Nat. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"E601","DOI":"10.1210\/jc.2014-2134","article-title":"Human uterine leiomyoma stem\/progenitor cells expressing CD34 and CD49b initiate tumors in vivo","volume":"100","author":"Yin","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/humrep\/12.9.2028","article-title":"Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix","volume":"12","author":"Alvarez","year":"1997","journal-title":"Hum. Reprod."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1067\/mob.2002.120485","article-title":"The influence of luteinizing hormone-releasing hormone analog on serum leptin and body composition in women with solitary uterine myoma","volume":"186","author":"Nowicki","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/humrep\/dep100","article-title":"Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial","volume":"24","author":"Engman","year":"2009","journal-title":"Hum. Reprod."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.fertnstert.2011.08.021","article-title":"Selective progesterone receptor modulators in reproductive medicine: Pharmacology, clinical efficacy and safety","volume":"96","author":"Bouchard","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.fertnstert.2015.09.006","article-title":"Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones","volume":"105","author":"Malik","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.fertnstert.2015.12.021","article-title":"Mifepristone inhibits extracellular matrix formation in uterine leiomyoma","volume":"105","author":"Patel","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1002\/ctm2.475","article-title":"Extracellular matrix and Hippo signaling as therapeutic targets of antifibrotic compounds for uterine fibroids","volume":"11","author":"Islam","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/13543784.2021.1957830","article-title":"Linzagolix: A new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas","volume":"30","author":"Dababou","year":"2021","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/humrep\/deac009","article-title":"Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids","volume":"37","author":"Middelkoop","year":"2022","journal-title":"Hum. Reprod."},{"key":"ref_47","first-page":"73","article-title":"Development of relugolix combination therapy as a medical treatment option for women with uterine fibroids or endometriosis","volume":"4","author":"Migoya","year":"2022","journal-title":"F&S Rep."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Salas, A., Garc\u00eda-Garc\u00eda, P., D\u00edaz-Rodr\u00edguez, P., \u00c9vora, C., Almeida, T.A., and Delgado, A. (2022). New local ganirelix sustained release therapy for uterine leiomyoma. Evaluation in a preclinical organ model. Biomed. Pharmacother., 156.","DOI":"10.1016\/j.biopha.2022.113909"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.xfre.2023.02.002","article-title":"Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix","volume":"4","author":"Chwalisz","year":"2023","journal-title":"F&S Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1158\/0008-5472.CAN-09-0541","article-title":"Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma","volume":"69","author":"Hu","year":"2009","journal-title":"Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1210\/en.2013-1929","article-title":"Inactivation of AKT induces cellular senescence in uterine leiomyoma","volume":"155","author":"Xu","year":"2014","journal-title":"Endocrinology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1021\/jm5004733","article-title":"Small molecule inhibitors targeting activator protein 1 (AP-1)","volume":"57","author":"Ye","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ygyno.2018.07.007","article-title":"HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas","volume":"150","author":"Galindo","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/gcc.22643","article-title":"Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2, and FH mutations","volume":"57","author":"Xie","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcancer.2019.07.009","article-title":"PI3K\/Akt\/mTOR inhibitors in cancer: At the bench and bedside","volume":"59","author":"Alzahrani","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.xfss.2020.04.001","article-title":"Characterization of the role of Activator Protein 1 signaling pathway on extracellular matrix deposition in uterine leiomyoma","volume":"1","author":"Pilgrim","year":"2020","journal-title":"F&S Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"8912","DOI":"10.1038\/s41598-022-12899-7","article-title":"Different DNA methylome, transcriptome and histological features in uterine fibroids with and without MED12 mutations","volume":"12","author":"Maekawa","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_58","first-page":"928","article-title":"Lichong decoction inhibits micro-angiogenesis by reducing the expressions of hypoxia inducible factor-1\u03b1 and vascular endothelial growth factor in hysteromyoma mouse model","volume":"40","author":"Wang","year":"2020","journal-title":"J. Tradit. Chin. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00404-017-4515-5","article-title":"Epigenetic and genetic landscape of uterine leiomyomas: A current view over a common gynecological disease","volume":"296","author":"Vergara","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Baranov, V.S., Osinovskaya, N.S., and Yarmolinskaya, M.I. (2019). Pathogenomics of Uterine Fibroids Development. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms20246151"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Navarro, A., Yin, P., Monsivais, D., Lin, S.M., Du, P., Wei, J.J., and Bulun, S.E. (2012). Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033284"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1518752113","article-title":"Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers","volume":"113","author":"Mehine","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2174\/1871520619666190409102855","article-title":"Transcriptome Analysis of mRNA in Uterine Leiomyoma Using Next-generation RNA Sequencing","volume":"19","author":"Anjum","year":"2019","journal-title":"Anticancer. Agents Med. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/gcc.20415","article-title":"A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas","volume":"46","author":"Wang","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1016\/j.celrep.2019.11.077","article-title":"Integrated Epigenome, Exome, and Transcriptome Analyzes Reveal Molecular Subtypes and Homeotic Transformation in Uterine Fibroids","volume":"29","author":"George","year":"2019","journal-title":"Cell Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.humpath.2017.12.005","article-title":"The selected biomarker analysis in 5 types of uterine smooth muscle tumors","volume":"76","author":"Zhang","year":"2018","journal-title":"Hum. Pathol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.fct.2018.07.030","article-title":"Resveratrol inhibits human leiomyoma cell proliferation via crosstalk between integrin \u03b1v\u03b23 and IGF-1R","volume":"120","author":"Ho","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/ng.805","article-title":"A genome-wide association study identifies three loci associated with susceptibility to uterine fibroids","volume":"43","author":"Cha","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ajhg.2012.08.009","article-title":"Genome-wide linkage and association analyses implicate FASN in predisposition to Uterine Leiomyomata","volume":"91","author":"Eggert","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00439-017-1836-1","article-title":"A multi-stage genome-wide association study of uterine fibroids in African Americans","volume":"136","author":"Hellwege","year":"2017","journal-title":"Hum. Genet."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e37110","DOI":"10.7554\/eLife.37110","article-title":"Genetic predisposition to uterine leiomyoma is determined by loci for genitourinary development and genome stability","volume":"7","author":"Kuisma","year":"2018","journal-title":"eLife"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1038\/s41467-018-05428-6","article-title":"Variants associating with uterine leiomyoma highlight genetic background shared by various cancers and hormone-related traits","volume":"9","author":"Rafnar","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1038\/s41467-019-12536-4","article-title":"Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis","volume":"10","author":"Gallagher","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(83)90386-0","article-title":"Therapeutic potential of the LHRH agonist, ICI 118630, in the treatment of advanced prostatic carcinoma","volume":"2","author":"Walker","year":"1983","journal-title":"Lancet"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-2133.2005.06769.x","article-title":"Expression of RPE65, a putative receptor for plasma retinol-binding protein, in nonmelanocytic skin tumours","volume":"153","author":"Hinterhuber","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1158\/1078-0432.CCR-08-3226","article-title":"MMP11: A novel target antigen for cancer immunotherapy","volume":"15","author":"Peruzzi","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1158\/0008-5472.CAN-09-2612","article-title":"Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells","volume":"70","author":"Yin","year":"2010","journal-title":"Cancer Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1210\/en.2014-1139","article-title":"Epigenetic regulation of uterine biology by transcription factor KLF11 via posttranslational histone deacetylation of cytochrome p450 metabolic enzymes","volume":"155","author":"Zheng","year":"2014","journal-title":"Endocrinology"},{"key":"ref_79","first-page":"3","article-title":"Matrix metalloproteinases and their inhibitors","volume":"2","author":"Grigorkevich","year":"2019","journal-title":"Pharmacokinet. Pharmacodyn."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1038\/s41388-019-0808-4","article-title":"H19 lncRNA has been identified as a master regulator of genes that control uterine leiomyomas","volume":"38","author":"Cao","year":"2019","journal-title":"Oncogene"},{"key":"ref_81","first-page":"247","article-title":"Latest Advances for the Treatment of Chronic Plaque Psoriasis with Biologics and Oral Small Molecules","volume":"15","author":"Bellinato","year":"2021","journal-title":"Biologics"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1055\/s-2005-864034","article-title":"Discovery, Chemistry, and Reproductive Pharmacology of Asoprisnil and Related 11\u03b2-Benzaldoxime Substituted Selective Progesterone Receptor Modulators (SPRMs)","volume":"23","author":"Schubert","year":"2005","journal-title":"Semin. Reprod. Med."}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/11\/4\/156\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:15:48Z","timestamp":1760130948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/11\/4\/156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":82,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["diseases11040156"],"URL":"https:\/\/doi.org\/10.3390\/diseases11040156","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,1]]}}}